Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DURECT Corporation - Common Stock (NQ:DRRX)

1.835 -0.035 (-1.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DURECT Corporation - Common Stock

< Previous 1 2 3 4 Next >
Dow Falls Over 100 Points; US Wholesale Inventories Edge Higher
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 100 points on Wednesday The Dow traded down 0.33% to 34,038.81 while the NASDAQ fell 0.28% to 13,601.60. The S&P 500... 
Via Benzinga
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Is Pain & Liver Disease Focused DURECT Stock Plunging Today?
DURECT Corporation (NASDAQ: DRRX) released topline  
Via Benzinga
US Stocks Higher; Kellanova Sales Top Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday Following the market opening Wednesday, the Dow traded up 0.27% to 34,244.50 while the NASDAQ rose 0.20%... 
Via Benzinga
Topics Stocks
Earnings Outlook For Durect
 
Via Benzinga
Analyst Ratings for Durect
 
Via Benzinga
Durect Earnings Preview
 
Via Benzinga
Cantor Fitzgerald Is Souring on Lucid Motors (LCID) Stock
Lucid Motors stock is falling after Cantor Fitzgerald analysts downgraded LCID shares and cut their price target following its Q3 earnings. 
Via InvestorPlace
Why Is Sleep Number (SNBR) Stock Down 40% Today?
Sleep Number stock is falling on Wednesday as investors in SNBR react to the company missing EPS and revenue estimates for Q3. 
Via InvestorPlace
Why Is Durect (DRRX) Stock Down 64% Today?
Durect stock is taking a beating on Wednesday as DRRX investors react to results from a Phase 2b clinical trial of larsucosterol. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. 
Via Benzinga
Durect Corp. (NASDAQ: DRRX) Making Surprising Moves in Monday Session
Via Investor Brand Network
Durect's Earnings Outlook
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
3 Promising Biotech Stocks That Will Make Early Investors Rich
Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies. 
Via InvestorPlace
Why AMC Entertainment Holdings Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) rose 45% to $0.2890 in pre-market trading after falling over 8% on Friday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
Via Benzinga
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid... 
Via Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
 
Via Benzinga
Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday
HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75 on... 
Via Benzinga
7 Stocks Under $10 to Buy in February
A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.